Primitive human hematopoietic progenitors adhere to P-selectin (CD62P)

Area of Science:

• Hematology
• Cell Biology
• Immunology

Background:

• P-selectin is a cell adhesion molecule involved in leukocyte trafficking and inflammation.
• Hematopoietic stem and progenitor cells (HSPCs) express CD34 and are crucial for blood cell formation.
• Understanding HSPC-P-selectin interactions is vital for stem cell transplantation and regenerative medicine.

Purpose of the Study:

• To investigate the binding of P-selectin to human hematopoietic progenitors.
• To identify the molecular nature of the P-selectin ligand on these primitive cells.
• To elucidate the role of sialic acid in this adhesion process.

Main Methods:

• Flow cytometry to analyze CD34+ cell binding to P-selectin.
• In vitro clonogenic assays to assess progenitor function.
• Enzymatic treatments (neuraminidase) and blocking antibodies to probe ligand structure.
• Reverse transcription polymerase chain reaction (RT-PCR) to detect P-selectin glycoprotein ligand-1 (PSGL-1) expression.

Main Results:

• P-selectin directly binds to committed (CFU-GM, BFU-E) and uncommitted (pre-CFU) human hematopoietic progenitors expressing CD34.
• Binding is cation-dependent, protease-sensitive, and abrogated by neuraminidase treatment, indicating a role for sialic acid.
• Monoclonal antibodies recognizing sialic acid-containing epitopes (CSLEX-1, HECA-452) bind to a subset of CD34+ cells and inhibit P-selectin binding.
• PSGL-1 is expressed on CD34+ cells, and its presence, along with the effect of HECA-452, suggests it's a key P-selectin ligand on these cells.

Conclusions:

• P-selectin interacts with primitive hematopoietic cells via sialic acid-dependent mechanisms.
• P-selectin glycoprotein ligand-1 (PSGL-1) is likely a major P-selectin ligand on CD34+ cells.
• These findings highlight the importance of P-selectin-PSGL-1 interactions in regulating HSPC behavior.